Canada Biotechnology & Medical Research

Thiogenesis Therapeutics Corp (TTI)

Track

Track

Thiogenesis Therapeutics Corp recorded two insider trading transactions over the past ninety days, both representing open market purchases. Directors Gilad Aharon and Brook Riggins acquired shares totaling 153,245 CAD. This activity follows the August 2026 results financiers, occurring while the stock price remains near its yearly low after a fourteen percent decline.
Ticker: TTI Exchange: CVE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Thiogenesis Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Riggins, Brook Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
180.73
Quantity 29,200 +39.0%
Value CA$2,125,717
Aharon, Gilad Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
439.80
Quantity 50,728 +37.7%
Value CA$2,821,904
Mullally, William Hogan Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
256.06
Quantity 95,290 +20.6%
Value CA$4,950,699
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.82
Quantity 200 +0.0%
Value CA$164
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.82
Quantity 16,000 +0.2%
Value CA$13,120
3.5
Riggins, Brook Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.75
Quantity 50,000 +5.0%
Value CA$37,500
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.56
Quantity 4,000 +0.1%
Value CA$2,240
2.6
Rioux, Patrice 10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer Executive Director Large shareholder
Transaction date
Purchase
Price
0.53
Quantity 12,000 +0.2%
Value CA$6,360
3.5
Riggins, Brook Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.44
Quantity 25,000 +2.6%
Value CA$11,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-01 2026-09-29 B Purchase
3.5
Riggins, Brook

Director of Issuer, Senior Officer of Issuer

Executive Director
29,200 +39.0%
180.73
CA$2,125,717 		29,200 +39.0% 180.73 CA$2,125,717
2026-09-23 2026-09-22 B Purchase
Aharon, Gilad

Director of Issuer

Non-Executive Director
50,728 +37.7%
439.80
CA$2,821,904 		50,728 +37.7% 439.80 CA$2,821,904
2025-08-01 2025-07-30 B Purchase
Mullally, William Hogan

Director of Issuer

Non-Executive Director
95,290 +20.6%
256.06
CA$4,950,699 		95,290 +20.6% 256.06 CA$4,950,699
2024-05-20 2024-02-05 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
200 +0.0%
0.82
CA$164 		200 +0.0% 0.82 CA$164
2024-05-20 2024-02-05 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
16,000 +0.2%
0.82
CA$13,120 		16,000 +0.2% 0.82 CA$13,120
2023-12-18 2023-12-15 B Purchase
3.5
Riggins, Brook

Director of Issuer, Senior Officer of Issuer

Executive Director
50,000 +5.0%
0.75
CA$37,500 		50,000 +5.0% 0.75 CA$37,500
2024-05-20 2023-03-31 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
4,000 +0.1%
0.56
CA$2,240 		4,000 +0.1% 0.56 CA$2,240
2024-05-20 2023-03-29 B Purchase
2.6
Rioux, Patrice

10% Security Holder of Issuer, Director of Issuer, Senior Officer of Issuer

Executive Director Large shareholder
12,000 +0.2%
0.53
CA$6,360 		12,000 +0.2% 0.53 CA$6,360
2022-08-02 2022-08-02 B Purchase
3.5
Riggins, Brook

Director of Issuer, Senior Officer of Issuer

Executive Director
25,000 +2.6%
0.44
CA$11,000 		25,000 +2.6% 0.44 CA$11,000
Explore more

More insider trading research around Thiogenesis Therapeutics Corp

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America